Analyst Coverage

Analyst Coverage

Firm Analyst
Canaccord Genuity Inc.
Arlinda Lee, Ph.D.
Cowen and Company
Marc Frahm, Ph.D.
Goldman, Sachs & Co.
Terence Flynn, Ph.D.
Guggenheim Securities
Michael Schmidt, Ph.D.
Jefferies
Eun Yang, Ph.D
Leerink Partners
Andrew Berens, M.D.
JMP Securities
Konstantinos Aprilakis, M.D.
Morgan Stanley
Under transition
Raymond James
Laura Chico, Ph.D.
Wedbush PacGrow Lifes Siences
David Nierengarten, Ph.D.

Blueprint Medicines Corp. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Blueprint Medicines Corp.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Blueprint Medicines Corp. or its management. Blueprint Medicines Corp. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.